As of Sep 30
| +1.41 / +4.07%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 29.50, with a high estimate of 50.00 and a low estimate of 12.00. The median estimate represents a -18.17% decrease from the last price of 36.05.
The current consensus among 8 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.